January. Morgan Stanley strategists think a range of factors will send it lower in the coming months.

A recession usually spells trouble for corporate profits and consumer spending, but Morgan Stanley sees a downturn as a ...

To put it another way, the median 89.5% recovery figure tells us it's very hard to pick winning stocks. Meanwhile, the ...

The U.S. dollar (DXY) is unlikely to lose much more value after already declining about 10% based on its index, according to ...

Given all the trouble Nvidia has selling its artificial-intelligence chips in China, one might wonder why the company even ...

It turns out that the stocks offering the best returns for investors historically experienced incredibly painful max ...

Crypto US stocks drop as GLXY, MARA, and GME face investor backlash despite bold Bitcoin and AI infrastructure moves.

FactSet estimates see first-quarter earnings of $0.73 per share and revenue of $43.3 billion, up 66 percent from a year ago.

We initiate MS with a Buy rating and $162 PT, as market underestimates durability and scale of earnings rebound underway.

Morgan Stanley shares rose 6.5% to $119.51, a new closing high, and its largest percentage gain since November 2020, according to Dow Jones Market Data.

Hinge Health's stock price will be closely watched in its IPO Thursday, after a challenging few years for the health tech ...

Financial benefits are a pathway forward.” Additional details are available in Morgan Stanley at Work’s State of the Workplace Study here. As part of a series of findings from Morgan Stanley ...